These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8925084)

  • 1. Quantitation of a new potent angiotensin II receptor antagonist, TCV-116, and its metabolites in human serum and urine.
    Miyabayashi T; Okuda T; Motohashi M; Izawa K; Yashiki T
    J Chromatogr B Biomed Appl; 1996 Feb; 677(1):123-32. PubMed ID: 8925084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of column-switching high-performance liquid chromatographic methods for the determination of a potent AII receptor antagonist, TCV-116, and its metabolites in human serum and urine.
    Lee JW; Naidong W; Johnson T; Dzerk A; Miyabayashi T; Motohashi M
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):287-98. PubMed ID: 8548019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Ritter MA; Furtek CI; Lo MW
    J Pharm Biomed Anal; 1997 Apr; 15(7):1021-9. PubMed ID: 9160270
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection.
    Stenhoff H; Lagerström PO; Andersen C
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):411-7. PubMed ID: 10510797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
    Furtek CI; Lo MW
    J Chromatogr; 1992 Jan; 573(2):295-301. PubMed ID: 1601963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method.
    Ferreirós N; Iriarte G; Alonso RM; Jiménez RM; Ortíz E
    J Sep Sci; 2008 Mar; 31(4):667-76. PubMed ID: 18307163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of conjugated metabolites of a new angiotensin II receptor antagonist, candesartan cilexetil, in rats by liquid chromatography/electrospray tandem mass spectrometry following chemical derivatization.
    Kondo T; Yoshida K; Yoshimura Y; Motohashi M; Tanayama S
    J Mass Spectrom; 1996 Aug; 31(8):873-8. PubMed ID: 8799313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the angiotensin II receptor antagonist, TCV-116, on blood pressure and the renin-angiotensin system in healthy subjects.
    Ogihara T; Nagano M; Mikami H; Higaki J; Kohara K; Azuma J; Aoki T; Hamanaka Y
    Clin Ther; 1994; 16(1):74-86. PubMed ID: 8205603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method.
    Daneshtalab N; Lewanczuk RZ; Jamali F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):345-9. PubMed ID: 11824822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
    Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K; Andersson OK; Wysocki M; Friberg P; Sunzel M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry.
    Polinko M; Riffel K; Song H; Lo MW
    J Pharm Biomed Anal; 2003 Sep; 33(1):73-84. PubMed ID: 12946533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection.
    González L; López JA; Alonso RM; Jiménez RM
    J Chromatogr A; 2002 Mar; 949(1-2):49-60. PubMed ID: 11999756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection.
    del Rosario Brunetto M; Contreras Y; Clavijo S; Torres D; Delgado Y; Ovalles F; Ayala C; Gallignani M; Estela JM; Martin VC
    J Pharm Biomed Anal; 2009 Sep; 50(2):194-9. PubMed ID: 19446420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC method transfer study for simultaneous determination of seven angiotensin II receptor blockers.
    Marghany KA; Abdelsalam RA; Haddad GM
    J Sep Sci; 2020 Apr; 43(8):1398-1405. PubMed ID: 31991050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin II receptor antagonist activities and mode of action of benzimidazole-7-carboxylic acid derivatives].
    Naka T
    Nihon Rinsho; 1993 Jun; 51(6):1575-9. PubMed ID: 8320837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent inhibition of the pressor and aldosterone responses to angiotensin-II by TCV-116 in normotensive subjects.
    Ogihara T; Nagano M; Higaki J; Kohara K; Mikami H
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):490-4. PubMed ID: 8583793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.